Munafa Stock Market Course + Intraday & FNO calls 
Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Apellis Pharmaceuticals (APLS)
Technical Analysis Report for USA stock APLS Apellis Pharmaceuticals. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock APLS Apellis Pharmaceuticals then click here. or read Experts views on Apellis Pharmaceuticals or Forecast & share price targets of Apellis Pharmaceuticals
Apellis Pharmaceuticals Opened at 22.24 and Closed at: 23.62, which is 6.05% of previous session's close. It moved within a range of 22.02 and 24.08
The session was a Bullish session with an average volume of 2635663, which is 2.81% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Golden cross was found 6 days back on short term averages
Support for tomorrow is 22.82 and resistance for tomorrow is 24.88
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 22.4, 21.18 resistance for tomorrow's hourly charts is 24.46, 25.3
10 Day SMA for Apellis Pharmaceuticals (APLS) is 21.26 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Apellis Pharmaceuticals (APLS) is 20.47 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Apellis Pharmaceuticals (APLS) is 22.95 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 23.69 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Apellis Pharmaceuticals is 22.01 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Apellis Pharmaceuticals is at 20.47 and 200 DMA is at 22.01, while 50 DMA and 100 DMA are at 22.95 and 23.69 respectively
Apellis Pharmaceuticals (APLS) moving average of 20 SMA is at 20.47 and 20 EMA is at 21.43
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 23.62 | 20.47 | 21.43 |
| 04 Thu Dec | 22.19 | 20.27 | 21.2 |
| 03 Wed Dec | 21.25 | 20.16 | 21.1 |
| 02 Tue Dec | 20.66 | 20.12 | 21.08 |
| 01 Mon Dec | 21.20 | 20.16 | 21.12 |
| 28 Fri Nov | 21.30 | 20.17 | 21.11 |
Apellis Pharmaceuticals (APLS) moving average of 50 SMA is at 22.95 and 50 EMA is at 22.36
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 23.62 | 22.95 | 22.36 |
| 04 Thu Dec | 22.19 | 22.92 | 22.31 |
| 03 Wed Dec | 21.25 | 22.93 | 22.31 |
| 02 Tue Dec | 20.66 | 22.97 | 22.35 |
| 01 Mon Dec | 21.20 | 23.03 | 22.42 |
| 28 Fri Nov | 21.30 | 23.06 | 22.47 |
Apellis Pharmaceuticals (APLS) moving average of 100 SMA is at 23.69 and 100 EMA is at 22.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 23.62 | 23.69 | 22.84 |
| 04 Thu Dec | 22.19 | 23.65 | 22.82 |
| 03 Wed Dec | 21.25 | 23.63 | 22.83 |
| 02 Tue Dec | 20.66 | 23.61 | 22.86 |
| 01 Mon Dec | 21.20 | 23.6 | 22.9 |
| 28 Fri Nov | 21.30 | 23.58 | 22.93 |
Apellis Pharmaceuticals (APLS) moving average of 200 SMA is at 22.01 and 200 EMA is at 24.06
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 23.62 | 22.01 | 24.06 |
| 04 Thu Dec | 22.19 | 22.03 | 24.06 |
| 03 Wed Dec | 21.25 | 22.06 | 24.08 |
| 02 Tue Dec | 20.66 | 22.09 | 24.11 |
| 01 Mon Dec | 21.20 | 22.13 | 24.14 |
| 28 Fri Nov | 21.30 | 22.16 | 24.17 |
Apellis Pharmaceuticals has performed better than Universal Health in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Cigna Corporation in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Dentsply Sirona in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Vanda Pharmaceuticals in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Utah Medical in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Tandem Diabetes has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 6% more returns!
Apellis Pharmaceuticals has performed better than Sellas Life in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Mannkind Corporation in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Moleculin Biotech has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1354.91% more returns!
Apellis Pharmaceuticals has performed better than Luminex Corporation in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Irhythm Technologies in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Integra Lifesciences in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Gossamer Bio has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Gossamer Bio, about 18.46% more returns!
Cellectis S has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Cellectis S, about 24.56% more returns!
Apellis Pharmaceuticals has performed better than Collplant Holdings in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Aytu Bioscience in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Amphastar Pharmaceuticals in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Align Technology in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals has performed better than Agios Pharmaceuticals in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Apellis Pharmaceuticals Technical analysis of indicators
Price action analysis of Apellis Pharmaceuticals (APLS) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Apellis Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Apellis Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Apellis Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.28 and Apellis Pharmaceuticals APLS stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Apellis Pharmaceuticals APLS stock. Volume based technical analysis of Apellis Pharmaceuticals APLS stock is negative.
Apellis Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock APLS Apellis Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And APLS Experts View which covers a lot of information including buying and selling signals
APLS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Apellis Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
